Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg Patients treated with baricitinib 4 mg saw significant regrowth of eyebrows and eyelashes at Week 36 compared to placebo Positive data underscore...
Read More Details
Finally We wish PressBee provided you with enough information of ( Lilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study )
Also on site :
- China’s navy conducts combat patrols near disputed South China Sea shoal
- Ilona Maher's Risqué 'Greek Goddess' Gown Leaves Fans 'Gasping for Air'
- Two Palestinians killed as Israeli forces open fire near aid center in Rafah